Jazz Pharmaceuticals

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$1,197,926
$1,126,107
$1,045,712
$897,841
Gross Profit
1,173,278
868,347
929,444
793,221
EBITDA
278,559
235,857
-514,182
138,861
EBIT
253,687
57,611
-688,191
-26,012
Net Income
203,451
251,412
-718,470
-92,541
Net Change In Cash
1,197,926
1,126,107
1,045,712
897,841
Free Cash Flow
296,789
459,441
100,888
390,903
Cash
1,391,899
1,236,070
1,189,880
1,861,946
Basic Shares
60,984
61,606
61,194
60,979

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$4,267,586
$4,068,950
$3,834,204
$3,659,374
Gross Profit
3,764,290
3,623,237
3,398,627
3,118,857
EBITDA
108,460
1,521,711
1,449,422
1,468,615
EBIT
-433,540
861,644
810,726
839,144
Net Income
-356,148
560,120
414,832
-224,060
Net Change In Cash
4,267,586
4,068,950
3,834,204
3,659,374
Cost of Revenue
296,256
Free Cash Flow
1,297,021
1,347,838
1,068,045
773,783
Cash
1,391,899
2,412,864
1,506,310
881,482
Basic Shares
60,984
66,007
72,066
62,539

Earnings Calls

QuarterEPS
2025-12-31
$6.64
2025-09-30
$8.13
2025-06-30
-$8.25
2025-03-31
-$1.52